← Back to catalogue

RELISA® Cardiolipin Antibody Screening Test

FDA UDI

by Immuno Concepts Inc

Identity

Trade Name
RELISA® Cardiolipin Antibody Screening Test FDA UDI
Generic Name
Anticardiolipin antibody IVD, kit, enzyme immunoassay (EIA) FDA UDI
Device Name
RELISA® Cardiolipin Antibody Screening Test System - 96 Tests FDA UDI
Model / Reference
7096-01 FDA UDI
Description
RELISA® Cardiolipin Antibody Screening Test System - 96 Tests FDA UDI

Identifiers

Catalog Number
7096-01 FDA UDI
Primary DI / UDI-DI
M7497096011 FDA UDI
GMDN Term
Anticardiolipin antibody IVD, kit, enzyme immunoassay (EIA) FDA UDI

Classification

Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

RELISA® Cardiolipin Antibody Screening Test by Immuno Concepts Inc — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Immuno Concepts Inc

Sources (1)

  • FDA UDI eefb58f5-5da7-48e7-b8be-ec3dd3ee175a 35 fields · synced Jun 1, 2026